The DOI matches its Crossref record; 120 of the 120 references it cites were found in a registry or an index.
Fatty acid oxidation: An emerging facet of metabolic transformation in cancer
Open accessAbstract
Cancer cells undergo metabolic reprogramming such as enhanced aerobic glycolysis, mutations in the tricarboxylic acid cycle enzymes, and upregulation of de novo lipid synthesis and glutaminolysis. These alterations are pivotal to the development and maintenance of the malignant phenotype of cancer cells in unfavorable tumor microenvironment or metastatic sites. Although mitochondrial fatty acid β-oxidation (FAO) is a primary bioenergetic source, it has not been generally recognized as part of the metabolic landscape of cancer. The last few years, however, have seen a dramatic change in the view of cancer relevance of the FAO pathway. Many recent studies have provided significant evidence to support a “lipolytic phenotype” of cancer. FAO, like other well-defined metabolic pathways involved in cancer, is dysregulated in diverse human malignancies. Cancer cells rely on FAO for proliferation, survival, stemness, drug resistance, and metastatic progression. FAO is also reprogrammed in cancer-associated immune and other host cells, which may contribute to immune suppression and tumor-promoting microenvironment. This article reviews and puts into context our current understanding of multi-faceted roles of FAO in oncogenesis as well as anti-cancer therapeutic opportunities posed by the FAO pathway.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Chen, C.-L., Uthaya Kumar, D. B., Punj, V., Xu, J., Sher, L., Tahara, S. M., Hess, S., & Machida, K. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2015.12.004 · Cited by 388
RetractedUnderstanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
Warburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425
Immunity, Inflammation, and Cancer
Grivennikov, S. I., Greten, F. R., & Karin, M. (2010) · Cell · doi:10.1016/j.cell.2010.01.025 · Cited by 10,755
The emerging hallmarks of cancer metabolism
Pavlova, N. N., & Thompson, C. B. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2015.12.006 · Cited by 5,926
IDH1 and IDH2 Mutations in Gliomas
Yan, H., Parsons, D. W., Jin, G., McLendon, R., Rasheed, B. A., Yuan, W., Kos, I., Batinic-Haberle, I., Jones, S., Riggins, G. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808710 · Cited by 5,847
The immune contexture in human tumours: impact on clinical outcome
Fridman, W. H., Pagès, F., Sautès-Fridman, C., & Galon, J. (2012) · Nature reviews. Cancer · doi:10.1038/nrc3245 · Cited by 4,981
Regulation of cancer cell metabolism
Cairns, R. A., Harris, I. S., & Mak, T. W. (2011) · Nature Reviews Cancer · doi:10.1038/nrc2981 · Cited by 4,744
Cancer drug resistance: an evolving paradigm
Holohan, C., Van Schaeybroeck, S., Longley, D. B., & Johnston, P. G. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3599 · Cited by 4,681
Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis
Menendez, J. A., & Lupu, R. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2222 · Cited by 2,941
The AMPK signalling pathway coordinates cell growth, autophagy and metabolism
Mihaylova, M. M., & Shaw, R. J. (2011) · Nature Cell Biology · doi:10.1038/ncb2329 · Cited by 2,923
Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth
Nieman, K. M., Kenny, H. A., Penicka, C. V., Ladanyi, A., Buell-Gutbrod, R., Zillhardt, M. R., Romero, I. L., Carey, M. S., Mills, G. B., Hotamisligil, G. S., et al. (2011) · Nature Medicine · doi:10.1038/nm.2492 · Cited by 2,279
Cellular Fatty Acid Metabolism and Cancer
Currie, E., Schulze, A., Zechner, R., Walther, T. C., & Farese, R. V. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.05.017 · Cited by 2,123
Michalek, R. D., Gerriets, V. A., Jacobs, S. R., Macintyre, A. N., MacIver, N. J., Mason, E. F., Sullivan, S. A., Nichols, A. G., & Rathmell, J. C. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003613 · Cited by 2,091
Immunosuppressive networks in the tumour environment and their therapeutic relevance
Zou, W. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1586 · Cited by 2,057
The multifaceted roles of fatty acid synthesis in cancer
Röhrig, F., & Schulze, A. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.89 · Cited by 1,651
Enhancing CD8 T-cell memory by modulating fatty acid metabolism
Pearce, E. L., Walsh, M. C., Cejas, P. J., Harms, G. M., Shen, H., Wang, L.-S., Jones, R. G., & Choi, Y. (2009) · Nature · doi:10.1038/nature08097 · Cited by 1,559
Mitochondrial respiratory capacity is a critical regulator of CD8+ T cell memory development
van der Windt, G. J. W., Everts, B., Chang, C.-H., Curtis, J. D., Freitas, T. C., Amiel, E., Pearce, E. J., & Pearce, E. L. (2012) · Immunity · doi:10.1016/j.immuni.2011.12.007 · Cited by 1,540
Targeting metastasis-initiating cells through the fatty acid receptor CD36
Pascual, G., Avgustinova, A., Mejetta, S., Martín, M., Castellanos, A., Attolini, C. S.-O., Berenguer, A., Prats, N., Toll, A., Hueto, J. A., et al. (2017) · Nature · doi:10.1038/nature20791 · Cited by 1,437
Oxidative metabolism and PGC-1β attenuate macrophage-mediated inflammation
Vats, D., Mukundan, L., Odegaard, J. I., Zhang, L., Smith, K. L., Morel, C. R., Greaves, D. R., Murray, P. J., & Chawla, A. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.05.011 · Cited by 1,369
Cancer metabolism: fatty acid oxidation in the limelight
Carracedo, A., Cantley, L. C., & Pandolfi, P. P. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3483 · Cited by 1,324
Cell-intrinsic lysosomal lipolysis is essential for alternative activation of macrophages
Huang, S. C.-C., Everts, B., Ivanova, Y., O'Sullivan, D., Nascimento, M., Smith, A. M., Beatty, W., Love-Gregory, L., Lam, W. Y., O'Neill, C. M., et al. (2014) · Nature Immunology · doi:10.1038/ni.2956 · Cited by 1,214
Antioxidant and oncogene rescue of metabolic defects caused by loss of matrix attachment
Schafer, Z. T., Grassian, A. R., Song, L., Jiang, Z., Gerhart-Hines, Z., Irie, H. Y., Gao, S., Puigserver, P., & Brugge, J. S. (2009) · Nature · doi:10.1038/nature08268 · Cited by 1,031
ER Stress Sensor XBP1 Controls Anti-tumor Immunity by Disrupting Dendritic Cell Homeostasis
Cubillos-Ruiz, J. R., Silberman, P. C., Rutkowski, M. R., Chopra, S., Perales-Puchalt, A., Song, M., Zhang, S., Bettigole, S. E., Gupta, D., Holcomb, K., et al. (2015) · Cell · doi:10.1016/j.cell.2015.05.025 · Cited by 933
The Biochemistry and Physiology of Mitochondrial Fatty Acid β-Oxidation and Its Genetic Disorders
Houten, S. M., Violante, S., Ventura, F. V., & Wanders, R. J. A. (2016) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021115-105045 · Cited by 920
Farge, T., Saland, E., de Toni, F., Aroua, N., Hosseini, M., Perry, R., Bosc, C., Sugita, M., Stuani, L., Fraisse, M., et al. (2017) · Cancer Discovery · doi:10.1158/2159-8290.cd-16-0441 · Cited by 912
Patra, K. C., Wang, Q., Bhaskar, P. T., Miller, L., Wang, Z., Wheaton, W., Chandel, N., Laakso, M., Muller, W. J., Allen, E. L., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.06.014 · Cited by 853
Wang, T., Fahrmann, J. F., Lee, H., Li, Y.-J., Tripathi, S. C., Yue, C., Zhang, C., Lifshitz, V., Song, J., Yuan, Y., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2017.11.001 · Cited by 825
Kantor, P. F., Lucien, A., Kozak, R., & Lopaschuk, G. D. (2000) · Circulation Research · doi:10.1161/01.res.86.5.580 · Cited by 813
Lipid accumulation and dendritic cell dysfunction in cancer
Herber, D. L., Cao, W., Nefedova, Y., Novitskiy, S. V., Nagaraj, S., Tyurin, V. A., Corzo, A., Cho, H.-I., Celis, E., Lennox, B., et al. (2010) · Nature Medicine · doi:10.1038/nm.2172 · Cited by 735
A PML–PPAR-δ pathway for fatty acid oxidation regulates hematopoietic stem cell maintenance
Ito, K., Carracedo, A., Weiss, D., Arai, F., Ala, U., Avigan, D. E., Schafer, Z. T., Evans, R. M., Suda, T., Lee, C.-H., et al. (2012) · Nature Medicine · doi:10.1038/nm.2882 · Cited by 729
Samudio, I., Harmancey, R., Fiegl, M., Kantarjian, H., Konopleva, M., Korchin, B., Kaluarachchi, K., Bornmann, W., Duvvuri, S., Taegtmeyer, H., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci38942 · Cited by 709
Bensaad, K., Favaro, E., Lewis, C. A., Peck, B., Lord, S., Collins, J. M., Pinnick, K. E., Wigfield, S., Buffa, F. M., Li, J.-L., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.08.056 · Cited by 665
Fatty acid carbon is essential for dNTP synthesis in endothelial cells
Schoors, S., Bruning, U., Missiaen, R., Queiroz, K. C. S., Borgers, G., Elia, I., Zecchin, A., Cantelmo, A. R., Christen, S., Goveia, J., et al. (2015) · Nature · doi:10.1038/nature14362 · Cited by 646 · cited 2×
“Other studies suggested the involvement of FAO metabolic intermediates as functional effectors of cell survival [8,9,22].”
BackgroundCarnitine palmitoyltransferases 1 and 2: biochemical, molecular and medical aspects
BONNEFONT, J. (2004) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2004.06.004 · Cited by 637
McGarry, J. D., Leatherman, G. F., & Foster, D. W. (1978) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)34693-8 · Cited by 600
Hossain, F., Al-Khami, A. A., Wyczechowska, D., Hernandez, C., Zheng, L., Reiss, K., Valle, L. D., Trillo-Tinoco, J., Maj, T., Zou, W., et al. (2015) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-15-0036 · Cited by 588
Regulation of fatty acid synthesis and oxidation by the AMP-activated protein kinase
Hardie, D. G., & Pan, D. A. (2002) · Biochemical Society Transactions · doi:10.1042/bst0301064 · Cited by 559
Fatty acid oxidation and carnitine palmitoyltransferase I: emerging therapeutic targets in cancer
Qu, Q., Zeng, F., Liu, X., Wang, Q. J., & Deng, F. (2016) · Cell Death & Disease · doi:10.1038/cddis.2016.132 · Cited by 545
Leukemic Stem Cells Evade Chemotherapy by Metabolic Adaptation to an Adipose Tissue Niche
Ye, H., Adane, B., Khan, N., Sullivan, T., Minhajuddin, M., Gasparetto, M., Stevens, B., Pei, S., Balys, M., Ashton, J. M., et al. (2016) · Cell Stem Cell · doi:10.1016/j.stem.2016.06.001 · Cited by 543
Metabolic Signatures Uncover Distinct Targets in Molecular Subsets of Diffuse Large B Cell Lymphoma
Caro, P., Kishan, A. U., Norberg, E., Stanley, I. A., Chapuy, B., Ficarro, S. B., Polak, K., Tondera, D., Gounarides, J., Yin, H., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.08.014 · Cited by 528
Inhibition of fatty acid oxidation as a therapy for MYC-overexpressing triple-negative breast cancer
Camarda, R., Zhou, A. Y., Kohnz, R. A., Balakrishnan, S., Mahieu, C., Anderton, B., Eyob, H., Kajimura, S., Tward, A., Krings, G., et al. (2016) · Nature Medicine · doi:10.1038/nm.4055 · Cited by 528
PPARs: Fatty acid sensors controlling metabolism
Poulsen, L. L. C., Siersbæk, M., & Mandrup, S. (2012) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2012.01.003 · Cited by 510
Zaugg, K., Yao, Y., Reilly, P. T., Kannan, K., Kiarash, R., Mason, J., Huang, P., Sawyer, S. K., Fuerth, B., Faubert, B., et al. (2011) · Genes & Development · doi:10.1101/gad.1987211 · Cited by 490
Pike, L. S., Smift, A. L., Croteau, N. J., Ferrick, D. A., & Wu, M. (2011) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2010.10.022 · Cited by 469
Glutaminolysis as a target for cancer therapy
Jin, L., Alesi, G. N., & Kang, S. (2016) · Oncogene · doi:10.1038/onc.2015.447 · Cited by 459
Mammary adipocytes stimulate breast cancer invasion through metabolic remodeling of tumor cells
Wang, Y. Y., Attané, C., Milhas, D., Dirat, B., Dauvillier, S., Guerard, A., Gilhodes, J., Lazar, I., Alet, N., Laurent, V., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.87489 · Cited by 455
The subcellular localization of acetyl-CoA carboxylase 2
Abu-Elheiga, L., Brinkley, W. R., Zhong, L., Chirala, S. S., Woldegiorgis, G., & Wakil, S. J. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.4.1444 · Cited by 453
Fatty acid oxidation is a dominant bioenergetic pathway in prostate cancer
Liu, Y. (2006) · Prostate Cancer and Prostatic Diseases · doi:10.1038/sj.pcan.4500879 · Cited by 433
Leamy, A. K., Egnatchik, R. A., & Young, J. D. (2013) · Progress in Lipid Research · doi:10.1016/j.plipres.2012.10.004 · Cited by 412
Lazar, I., Clement, E., Dauvillier, S., Milhas, D., Ducoux-Petit, M., LeGonidec, S., Moro, C., Soldan, V., Dalle, S., Balor, S., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-0651 · Cited by 387
Fatty acid oxidation in macrophage polarization
Nomura, M., Liu, J., Rovira, I. I., Gonzalez-Hurtado, E., Lee, J., Wolfgang, M. J., & Finkel, T. (2016) · Nature Immunology · doi:10.1038/ni.3366 · Cited by 386
CPT1A-mediated fatty acid oxidation promotes colorectal cancer cell metastasis by inhibiting anoikis
Wang, Y.-N., Zeng, Z.-L., Lu, J., Wang, Y., Liu, Z.-X., He, M.-M., Zhao, Q., Wang, Z.-X., Li, T., Lu, Y.-X., et al. (2018) · Oncogene · doi:10.1038/s41388-018-0384-z · Cited by 380
Buzzai, M., Bauer, D. E., Jones, R. G., DeBerardinis, R. J., Hatzivassiliou, G., Elstrom, R. L., & Thompson, C. B. (2005) · Oncogene · doi:10.1038/sj.onc.1208622 · Cited by 357
Paumen, M. B., Ishida, Y., Muramatsu, M., Yamamoto, M., & Honjo, T. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.6.3324 · Cited by 349
Metabolism of [U‐ 13 C]glucose in human brain tumors in vivo
Maher, E. A., Marin‐Valencia, I., Bachoo, R. M., Mashimo, T., Raisanen, J., Hatanpaa, K. J., Jindal, A., Jeffrey, F. M., Choi, C., Madden, C., et al. (2012) · NMR in Biomedicine · doi:10.1002/nbm.2794 · Cited by 341
Mechanisms of metabolic dysfunction in cancer-associated cachexia
Petruzzelli, M., & Wagner, E. F. (2016) · Genes & Development · doi:10.1101/gad.276733.115 · Cited by 340
Corbet, C., Pinto, A., Martherus, R., Santiago de Jesus, J. P., Polet, F., & Feron, O. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.07.003 · Cited by 336
The role of fatty acid β-oxidation in lymphangiogenesis
Wong, B. W., Wang, X., Zecchin, A., Thienpont, B., Cornelissen, I., Kalucka, J., García-Caballero, M., Missiaen, R., Huang, H., Brüning, U., et al. (2017) · Nature · doi:10.1038/nature21028 · Cited by 336
Self-citationFatty acid transport across the cell membrane: Regulation by fatty acid transporters
Schwenk, R. W., Holloway, G. P., Luiken, J. J. F. P., Bonen, A., & Glatz, J. F. C. (2010) · Prostaglandins, Leukotrienes and Essential Fatty Acids (PLEFA) · doi:10.1016/j.plefa.2010.02.029 · Cited by 318
Dobbins, R. L., Szczepaniak, L. S., Bentley, B., Esser, V., Myhill, J., & McGarry, J. D. (2001) · Diabetes · doi:10.2337/diabetes.50.1.123 · Cited by 315
Therapeutic targets in cancer cell metabolism and autophagy
Cheong, H., Lu, C., Lindsten, T., & Thompson, C. B. (2012) · Nature Biotechnology · doi:10.1038/nbt.2285 · Cited by 315
Park, J. H., Vithayathil, S., Kumar, S., Sung, P.-L., Dobrolecki, L. E., Putluri, V., Bhat, V. B., Bhowmik, S. K., Gupta, V., Arora, K., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.02.004 · Cited by 313
Lipid Catabolism via CPT1 as a Therapeutic Target for Prostate Cancer
Schlaepfer, I. R., Rider, L., Rodrigues, L. U., Gijón, M. A., Pac, C. T., Romero, L., Cimic, A., Sirintrapun, S. J., Glodé, L. M., Eckel, R. H., et al. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-14-0183 · Cited by 304
Padanad, M. S., Konstantinidou, G., Venkateswaran, N., Melegari, M., Rindhe, S., Mitsche, M., Yang, C., Batten, K., Huffman, K. E., Liu, J., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.07.009 · Cited by 301
Wen, Y.-A., Xing, X., Harris, J. W., Zaytseva, Y. Y., Mitov, M. I., Napier, D. L., Weiss, H. L., Mark Evers, B., & Gao, T. (2017) · Cell Death & Disease · doi:10.1038/cddis.2017.21 · Cited by 291
Effert, P. J., Bares, R., Handt, S., Wolff, J. M., Büll, U., & Jakse, G. (1996) · PubMed · Cited by 289
Zhao, F., Xiao, C., Evans, K. S., Theivanthiran, T., DeVito, N., Holtzhausen, A., Liu, J., Liu, X., Boczkowski, D., Nair, S., et al. (2018) · Immunity · doi:10.1016/j.immuni.2017.12.004 · Cited by 289
A metabolic prosurvival role for PML in breast cancer
Carracedo, A., Weiss, D., Leliaert, A. K., Bhasin, M., de Boer, V. C. J., Laurent, G., Adams, A. C., Sundvall, M., Song, S. J., Ito, K., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci62129 · Cited by 269
Fatty acid oxidation is required for the respiration and proliferation of malignant glioma cells
Lin, H., Patel, S., Affleck, V. S., Wilson, I., Turnbull, D. M., Joshi, A. R., Maxwell, R., & Stoll, E. A. (2017) · Neuro-Oncology · doi:10.1093/neuonc/now128 · Cited by 260
Gatza, M. L., Silva, G. O., Parker, J. S., Fan, C., & Perou, C. M. (2014) · Nature Genetics · doi:10.1038/ng.3073 · Cited by 258
Hofer, C., Laubenbacher, C., Block, T., Breul, J., Härtung, R., & Schwaiger, M. (1999) · European Urology · doi:10.1159/000019923 · Cited by 252
Effert, P. J., Bares, R., Handt, S., Wolff, J. M., Bull, U., & Jakse, G. (1996) · Journal of Urology · doi:10.1016/s0022-5347(01)66366-3 · Cited by 240
Ricciardi, M. R., Mirabilii, S., Allegretti, M., Licchetta, R., Calarco, A., Torrisi, M. R., Foà, R., Nicolai, R., Peluso, G., & Tafuri, A. (2015) · Blood · doi:10.1182/blood-2014-12-617498 · Cited by 222
Excessive fatty acid oxidation induces muscle atrophy in cancer cachexia
Fukawa, T., Yan-Jiang, B. C., Min-Wen, J. C., Jun-Hao, E. T., Huang, D., Qian, C.-N., Ong, P., Li, Z., Chen, S., Mak, S. Y., et al. (2016) · Nature Medicine · doi:10.1038/nm.4093 · Cited by 207
Yao, C.-H., Liu, G.-Y., Wang, R., Moon, S. H., Gross, R. W., & Patti, G. J. (2018) · PLOS Biology · doi:10.1371/journal.pbio.2003782 · Cited by 206
Targeting Peroxisome Proliferator-Activated Receptors (PPARs): Development of Modulators
Pirat, C., Farce, A., Lebègue, N., Renault, N., Furman, C., Millet, R., Yous, S., Speca, S., Berthelot, P., Desreumaux, P., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm101360s · Cited by 198 · cited 1×
“PPARα has been shown to stimulate CPT1A transcription in the liver by binding to the peroxisome proliferator response element on the CPT1A gene promoter [30].”
BackgroundSierra, A. Y., Gratacós, E., Carrasco, P., Clotet, J., Ureña, J., Serra, D., Asins, G., Hegardt, F. G., & Casals, N. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m707965200 · Cited by 190
Liu, Y., Zuckier, L. S., & Ghesani, N. V. (2010) · PubMed · Cited by 183
Targeting Mitochondria with Avocatin B Induces Selective Leukemia Cell Death
Lee, E. A., Angka, L., Rota, S.-G., Hanlon, T., Mitchell, A., Hurren, R., Wang, X. M., Gronda, M., Boyaci, E., Bojko, B., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-2676 · Cited by 179
Self-citationAshrafian, H., Horowitz, J. D., & Frenneaux, M. P. (2007) · Cardiovascular Drug Reviews · doi:10.1111/j.1527-3466.2007.00006.x · Cited by 173
PHD3 Loss in Cancer Enables Metabolic Reliance on Fatty Acid Oxidation via Deactivation of ACC2
German, N. J., Yoon, H., Yusuf, R. Z., Murphy, J. P., Finley, L. W. S., Laurent, G., Haas, W., Satterstrom, F. K., Guarnerio, J., Zaganjor, E., et al. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.08.014 · Cited by 156
Carnitine palmitoyltransferase 1C: From cognition to cancer
Casals, N., Zammit, V. A., Herrero, L., Fadó, R., Rodríguez‐Rodríguez, R., & Serra, D. (2015) · Progress in Lipid Research · doi:10.1016/j.plipres.2015.11.004 · Cited by 154
Al-Khami, A. A., Hossain, F. M., Wyczechowska, D. D., Hernandez, C., Zheng, L., Reiss, K., Valle, L. D., Trillo-Tinoco, J., Maj, T., Zou, W., et al. (2015) · Journal for ImmunoTherapy of Cancer · doi:10.1186/2051-1426-3-s2-o18 · Cited by 151
Keung, W., Ussher, J. R., Jaswal, J. S., Raubenheimer, M., Lam, V. H., Wagg, C. S., & Lopaschuk, G. D. (2012) · Diabetes · doi:10.2337/db12-0259 · Cited by 142
Inborn Errors of Long-Chain Fatty Acid β-Oxidation Link Neural Stem Cell Self-Renewal to Autism
Xie, Z., Jones, A. R., Deeney, J. T., Hur, S. K., & Bankaitis, V. A. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.01.004 · Cited by 122
Weis, B. C., Cowan, A. T., Brown, N., Foster, D. W., & McGarry, J. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47214-6 · Cited by 121
Shao, H., Mohamed, E. M., Xu, G.-Y. G., Waters, M., Jing, K., Ma, Y., Zhang, Y., Spiegel, S., Idowu, M., & Fang, X.-J. (2015) · OncoTarget · doi:10.18632/oncotarget.6757 · Cited by 119
Self-citationCeccarelli, S. M., Chomienne, O., Gubler, M., & Arduini, A. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm100809g · Cited by 118
Cook, K. L., Soto‐Pantoja, D. R., Clarke, P. A. G., Cruz, M. I., Zwart, A. L., Wärri, A. M., Hilakivi-Clarke, L. A., Roberts, D. D., & Clarke, R. C. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-2616 · Cited by 118
Inhibition of Fatty Acid Metabolism Reduces Human Myeloma Cells Proliferation
Tirado-Vélez, J. M., Joumady, I., Sáez-Benito, A., Cózar‐Castellano, I., & Perdomo, G. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046484 · Cited by 115
Pacilli, A., Calienni, M., Margarucci, S., D’Apolito, M., Petillo, O., Rocchi, L., Pasquinelli, G., Nicolai, R., Koverech, A., Calvani, M., et al. (2013) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djt030 · Cited by 114
PPARα and fatty acid oxidation mediate glucocorticoid resistance in chronic lymphocytic leukemia
Tung, S., Shi, Y., Wong, K., Zhu, F., Gorczynski, R., Laister, R. C., Minden, M. D., Blechert, A.-K., Genzel, Y., Reichl, U., et al. (2013) · Blood · doi:10.1182/blood-2013-03-489468 · Cited by 104
Carnitine palmitoyltransferase 1: Central to cell function
Zammit, V. A. (2008) · IUBMB Life · doi:10.1002/iub.78 · Cited by 100
Acetyl-CoA carboxylase-a as a novel target for cancer therapy.
Wang, C., Rajput, S., Watabe, K., Liao, D.-F., & Cao, D. (2010) · Frontiers in Bioscience · doi:10.2741/s82 · Cited by 95
Liu, P.-P., Liu, J., Jiang, W.-Q., Carew, J. S., Ogasawara, M. A., Pelicano, H., Croce, C. M., Estrov, Z., Xu, R., Keating, M., et al. (2016) · Oncogene · doi:10.1038/onc.2016.103 · Cited by 94
Kennedy, J. A., Kiosoglous, A. J., Murphy, G. A., Pelle, M. A., & Horowitz, J. D. (2000) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200012000-00016 · Cited by 89
Shi, J.-L., Fu, H.-P., Jia, Z.-L., He, K., Fu, L., & Wang, W.-D. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.11.025 · Cited by 84
Self-citationLinher‐Melville, K., Zantinge, S., Sanli, T., Gerstein, H. C., Tsakiridis, T. K., & Singh, G. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-56 · Cited by 83
Lipid degradation promotes prostate cancer cell survival
Itkonen, H. M., Brown, M. D., Urbanucci, A., Tredwell, G. D., Lau, C. E., Barfeld, S. J., Hart, C. A., Guldvik, I. J., Takhar, M., Heemers, H. V., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.16123 · Cited by 79
Wang, M.-D., Wu, H., Huang, S., Zhang, H., Qin, C., Zhao, L., Fu, G., Zhou, X., Wang, X., Tang, L., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.6817 · Cited by 76
Self-citationPET Tracers Beyond FDG in Prostate Cancer
Schuster, D. M., Nanni, C., & Fanti, S. (2016) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2016.07.005 · Cited by 76
Merrill, C. L. (2002) · Toxicological Sciences · doi:10.1093/toxsci/68.1.93 · Cited by 75
Halama, A., Kuliński, M., Dib, S. S., Zaghlool, S. B., Siveen, K. S., Iskandarani, A., Zierer, J., Prabhu, K. S., Satheesh, N. J., Bhagwat, A. M., et al. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.05.017 · Cited by 75
Schlaepfer, I. R., Glodé, L. M., Hitz, C. A., Pac, C. T., Boyle, K. E., MARONI, P. D., Deep, G., Agarwal, R., Lucia, S. M., Cramer, S. D., et al. (2015) · Molecular Imaging and Biology · doi:10.1007/s11307-014-0814-4 · Cited by 74
Giordano, A., Calvani, M., Petillo, O., Grippo, P., Tuccillo, F. M., Melone, M. A. B., Bonelli, P., Calarco, A., & Peluso, G. (2005) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401636 · Cited by 68
Molecular Pathways: Tumor Cells Co-opt the Brain-Specific Metabolism Gene CPT1C to Promote Survival
Reilly, P. T., & Mak, T. W. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-3281 · Cited by 68
Metabolomic profiling reveals a role for CPT1c in neuronal oxidative metabolism
Lee, J., & Wolfgang, M. J. (2012) · BMC Biochemistry · doi:10.1186/1471-2091-13-23 · Cited by 64
Halldórsson, S., Rohatgi, N., Magnúsdóttir, M., Choudhary, K. S., Guðjónsson, Þ., Knutsen, E., Barkovskaya, A., Hilmarsdóttir, B., Perander, M., Mælandsmo, G. M., et al. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.03.019 · Cited by 63
Shinohara, H., Kumazaki, M., Minami, Y., Ito, Y., Sugito, N., Kuranaga, Y., Taniguchi, K., Yamada, N. O., Otsuki, Y., Naoe, T., et al. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.11.020 · Cited by 60
Wu, Y., Hurren, R., MacLean, N., Gronda, M., Jitkova, Y., Sukhai, M. A., Minden, M. D., & Schimmer, A. D. (2015) · APOPTOSIS · doi:10.1007/s10495-015-1137-x · Cited by 54
Heřmanová, I., Arruabarrena-Aristorena, A., Vališ, K., Nůsková, H., Alberich-Jordà, M., Fišer, K., Fernández‐Ruiz, S., Kavan, D., Pecinová, A., Niso‐Santano, M., et al. (2015) · Leukemia · doi:10.1038/leu.2015.213 · Cited by 52
Kitajima, S., Yoshida, A., Kohno, S., Li, F., Suzuki, S., Nagatani, N., Nishimoto, Y., Sasaki, N., Muranaka, H., Wan, Y., et al. (2017) · Oncogene · doi:10.1038/onc.2017.124 · Cited by 51
Li, J., Zhao, S., Zhou, X., Zhang, T., Zhao, L., Miao, P., Song, S., Sun, X., Liu, J., Zhao, X., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0074623 · Cited by 48
Ma, Y., Yu, C., Mohamed, E., Shao, H., Wang, L., Sundaresan, G., Zweit, J., Idowu, M. O., & Fang, X. (2016) · Oncogene · doi:10.1038/onc.2016.150 · Cited by 47
Self-citationS6K1 determines the metabolic requirements for BCR-ABL survival
Barger, J. F., Gallo, C. A., Tandon, P., Liu, H., Sullivan, A. P., Grimes, H. L., & Plas, D. R. (2012) · Oncogene · doi:10.1038/onc.2012.70 · Cited by 45
Chronic inhibition of fatty acid oxidation: New model of diastolic dysfunction
BRESSLER, R. C., Gay, R. G., Copeland, J. G., Bahl, J. J., Bedotto, J. B., & Goldman, S. (1989) · Life Sciences · doi:10.1016/0024-3205(89)90401-3 · Cited by 44
Yan, X., Zhang, G., Bie, F., Lv, Y., Ma, Y., Ma, M., Wang, Y., Hao, X., Yuan, N., & Jiang, X. (2017) · Scientific Reports · doi:10.1038/s41598-017-13505-x · Cited by 41
Self-citationImpact of mitochondrial β-oxidation in fatty acid-mediated inhibition of glioma cell proliferation
Berge, K., Tronstad, K. J., Bohov, P., Madsen, L., & Berge, R. K. (2003) · Journal of Lipid Research · doi:10.1194/jlr.m200312-jlr200 · Cited by 39
Bagger, J. P., Bøtker, H. E., Thomassen, A. R., & Nielsen, T. T. (1997) · Cardiovascular Drugs and Therapy · doi:10.1023/a:1007705707667 · Cited by 29
Cited by
Greasing the Wheels of the Cancer Machine: The Role of Lipid Metabolism in Cancer
Snaebjornsson, M. T., Janaki-Raman, S., & Schulze, A. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2019.11.010 · Cited by 1,097
Bian, X., Liu, R., Meng, Y., Xing, D., Xu, D., & Lu, Z. (2021) · Journal of Experimental Medicine · doi:10.1084/jem.20201606 · Cited by 983
Mechanisms of Metabolic Reprogramming in Cancer Cells Supporting Enhanced Growth and Proliferation
Schiliro, C., & Firestein, B. L. (2021) · Cells · doi:10.3390/cells10051056 · Cited by 615
Lipids and cancer: Emerging roles in pathogenesis, diagnosis and therapeutic intervention
Butler, L. M., Perone, Y., Dehairs, J., Lupien, L. E., de Laat, V., Talebi, A., Loda, M., Kinlaw, W. B., & Swinnen, J. V. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.07.013 · Cited by 589
Altered metabolism in cancer: insights into energy pathways and therapeutic targets
Tufail, M., Jiang, C.-H., & Li, N. (2024) · Molecular Cancer · doi:10.1186/s12943-024-02119-3 · Cited by 534
Metadata
- Authors
- Ma, Y., Temkin, S. M., Hawkridge, A. M., Guo, C., Wang, W., Wang, X.-Y., & Fang, X.
- Venue
- Cancer Letters
- Publisher
- Elsevier BV
- Published
- 2018-10
- Volume
- 435
- Pages
- 92-100
- ISSN
- 0304-3835 (ISSN-L)
- OpenAlex
- W2885029979
- Cited by
- 531
- References
- 120
- FWCI
- 7.32
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.